SCHEMBL23938218

SCHEMBL23938218

COCC1CC(N)CN1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24729631 0.78 PDK1 (0.30) —
SCHEMBL376497 0.71 MMP2 (0.42) —
SCHEMBL22557040 0.71 MMP2 (0.42) —
SCHEMBL13661933 0.71 — —
SCHEMBL3955349 0.71 MMP2 (0.42) —
SCHEMBL7298747 0.65 MAPT (0.42) —
SCHEMBL7307421 0.65 MAPT (0.42) —
SCHEMBL21335566 0.64 — —
SCHEMBL13039826 0.63 — —
SCHEMBL29788904 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323975-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS VALO EARLY DISCOVERY, INC. 2021-10-21 — — US disclosed
Send feedback